Tara Sarin
Allergy & Immunology · Murray, UTNPI 1760860134
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,166 of the $19,899 with a category attached, or 61.1%. 34 manufacturers reported payments, led by AstraZeneca at 32.5% of the total.
Across 495 payments — averaging $40.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$6K
- Sanofi$4K
- Genentech USA, Inc.$2K
- Pharming Healthcare, Inc.$1K
- Novartis$667
- Takeda Pharmaceuticals U.S.A., Inc.$665
- plus $5K from 28 others
What the payments were for
- Consulting fees$6,69134%
- Speaking & faculty fees$1751%
- Grants$7004%
- Food & beverage$12,16661%
- Education$1661%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 107 | $6,470 |
| Sanofi | 84 | $4,173 |
| Genentech USA, Inc. | 14 | $2,217 |
| Pharming Healthcare, Inc. | 22 | $1,126 |
| Novartis | 33 | $667 |
| Takeda Pharmaceuticals U.S.A., Inc. | 33 | $665 |
| GSK | 37 | $586 |
| Amgen | 14 | $418 |
| Regeneron Healthcare Solutions, Inc. | 16 | $373 |
| Kaleo, Inc. | 18 | $362 |
| Grifols USA, LLC | 12 | $275 |
| Aimmune Therapeutics, Inc. | 5 | $268 |
| CSL Behring | 10 | $246 |
| Optinose US, Inc. | 13 | $226 |
| Teva Pharmaceuticals USA, Inc. | 13 | $204 |
| Pfizer | 11 | $191 |
| Regeneron | 2 | $183 |
| LEO Pharma Inc. | 7 | $180 |
| ARS Pharmaceuticals Operations, Inc. | 11 | $170 |
| Incyte Corporation | 4 | $138 |
| AbbVie | 2 | $119 |
| Blueprint Medicines Corporation | 4 | $101 |
| Genentech, Inc. | 1 | $89 |
| Biocryst US Sales Co., LLC | 3 | $88 |
| Boehringer Ingelheim | 4 | $73 |
| Ionis Pharmaceuticals, Inc. | 3 | $56 |
| Mylan Specialty L.p. | 3 | $55 |
| Galderma Laboratories, L.p. | 2 | $52 |
| Greer Laboratories, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
| Organon | 2 | $21 |
| Octapharma USA, Inc. | 1 | $20 |
| Tersera Therapeutics LLC | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,899 in reported general payments places this provider in the 85th percentile of 30 allergy & immunology providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breo ElliptaFluticasone/Vilanterol | 45 | $24,597 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $14,980 |
| Spiriva RespimatTiotropium Bromide | 12 | $12,345 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $11,430 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $6,982 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 43 | $5,843 |
| DuleraMometasone/Formoterol | 12 | $4,670 |
| Epinephrine | 22 | $3,375 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 13 | $2,906 |
| Mometasone Furoate | 27 | $2,402 |
| Asmanex HfaMometasone Furoate | 14 | $2,079 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 56 | $1,624 |
| Ipratropium Bromide | 36 | $1,082 |
| Montelukast Sodium | 57 | $971 |
| Azelastine Hcl | 21 | $940 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Trelegy Ellipta | $586 | $39,57760 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $6,470 | $18,41232 claims |
| Boehringer IngelheimSpiriva Respimat | $73 | $12,34512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 30 allergy & immunology providers in Utah.
Other allergy & immunology in Murray
- Loida Viera HutchinsMurray$8K
- David GourleyMurray$496
- Andrew SmithSandy$649K
- Jonathan OlsenDraper$60K
- Jaron AbbottProvo$22K
- Richard HendershotPark City$16K
- Stephen BodenBountiful$7K
- Alexander NicholsonWest Jordan$7K
- Joshua BurkhardtSalem$6K
- Evan MathesonProvo$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.